The open index of psychedelic research

Dataset and Analysis Code Supporting "Asymmetric Impacts of Supply- and Demand-Driven Flash Droughts on Leaf Senescence"

Anonymous, Authors

Remifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality

Longitudinal Assessment of Ketamine-Assisted Community of Practice Therapy: A Retrospective 5-Year Study on Depression, Anxiety and PTSD

Kuzma-Hunt A, Hamadeh Z, Tsang V

Esketamine vs. sufentanil for quality of recovery after outpatient gynecological surgery: a randomized clinical trial.

Wang XL, Li YN, Ma QL +6

Psilocybin-induced changes in electroencephalography link acute and long-term effects.

Nikolič M, Froese T, Mediano PAM +4

Clinical Outcomes of Ketamine Therapy for Depression, Anxiety, and PTSD in Post-TBI Patients

Aldulaimy W, Shah A

Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical Trial.

Cui X, Chen W, Wang J +7

What is the current status of research for esketamine in the treatment of bipolar depression? A literature review

Vasiliu O, Vasiliu D

One dose of Psilocybin modulates Brain Activity among Depressive patients : Preliminary Neuroimaging Results from the PSILODAC Study

Pastre M, Pereira F, Gibert T +6

Esketamine Treatment and Its Impact on Suicidality in Treatment-Resistant Depression: A Narrative Review

Mândraș I, Comșa A

Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report

Angeletti M, La Monica K, Casati V +9

Reduction of Suicidality and Depressive Symptoms with Esketamine: Focus on Gender Differences

Martiadis V, Raffone F, Testa S +7

Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections

Casati V, La Monica K, Angeletti M +11

Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Early Outcomes from Poland’s First Psychiatric Drug Program B.147

Płaza O, Madejek R, Dutsch-Wicherek M +2

Esketamine Use in Treatment-Resistant Depression with Comorbid ADHD and Autistic Traits: A Case Report

Cindik-Herbrueggen E, Kucukali A

The association between anhedonia and quality of life in treatment-resistant depression: effects of a three-month treatment with esketamine nasal spray

Marcelli I, Pepe M, Specogna E +8

Fast recovery from treatment resistant depression: clinical case from HIPOCRAT-ESK study, a cohort, non-interventional, prospective, real-world study of functional remission in TRD patients treated with Esketamine nasal spray

Caraballo Lopez T, Sierra San Miguel M, Cañada Pérez Y +2

Does Intranasal Esketamine Show Differential Efficacy with SSRIs versus SNRIs in Treatment-Resistant Depression?

Pompili M, Trocchia M, Di Biase G +5

The effect of the Apollo Neuro device on anxiety among participants who underwent ketamine assisted therapy: A non-randomized, observational cohort study

Wong S, Tsang V, Tao B +4

Long-Term Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: A Real-World, Single-arm Study of Over 100 sessions

Ayad N, Makhoul S

Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression

Versaci G, Olivola M, La Monica K +11

Long-term maintenance therapy with ketamine infusions for treatment-resistant depression: a retrospective chart review

Peters E, Al Hasani A, Shukla K +1

Electroconvulsive Therapy and (Es)Ketamine in Treatment-Resistant Depression: A Review of Current Evidence

Marta J, Ferreira Â, Batista C +3

ECHO: Results from a Non-Interventional Cohort Study of Esketamine Nasal Spray in Treatment Resistant Depression

Rosso G, Constant E, De Filippis S +12